Cargando…
Successful Early Treatment of Severe Neonatal Hyperparathyroidism With Cinacalcet
Introduction: Neonatal severe hyperaparathyroidism (NSHPT) can cause significant bone disease early in life and prompt treatment is therefore necessary. Cinacalcet is a calcimimetic primarily used in adult patients with hypercalcemia to treat secondary hyperparathyroidism, but has only been trialed...
Autores principales: | Thakkar, Keya, Romero, Christopher Joseph, Rapaport, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089903/ http://dx.doi.org/10.1210/jendso/bvab048.457 |
Ejemplares similares
-
RF30 | PSAT178 Severe Hyperparathyroidism in a Newborn: Response to Cinacalcet
por: Welch, Lurah, et al.
Publicado: (2022) -
SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020) -
SUN-509 A Challenging Case of Symptomatic Primary Hyperparathyroidism during Pregnancy Treated with Cinacalcet
por: Rodriguez, Aleida, et al.
Publicado: (2019) -
SAT-355 Severe Symptomatic Hypocalcemia Related to Cinacalcet Administration Introduction
por: Weaver, Travis, et al.
Publicado: (2020) -
MON-541 Successful Treatment of Normocalcemic Hyperparathyroidism in Children
por: Papadimitriou, Dimitrios, et al.
Publicado: (2019)